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Abstract Resumen 
Context: Candida albicans is a pathogenic fungus that causes vulvovaginal 
candidiasis (VVC), which presents significant clinical problems in 
immunocompromised patients. There are no studies that correlate IgM 
antibody responses and fungal loads following the use of ethanol leaf 
extract of Plectranthus scutellarioides (L.) R.Br. (ELEP) on VVC. 
Aims: To examine colony fungi loads, IgM antibody responses, and their 
correlation in Balb/c mice infected with C. albicans treated with orally 
administered ELEP. 
Methods: Twenty-five female Balb/c mice were randomly divided into five 
groups (five mice in each group): normal group (oral ELEP + not 
infected), VVC control (VCC) group (infected + oral 0.2 mL saline), 
ketoconazole-treated in VCC group (infected + oral antifungal agents), 
and two treatment groups (infected + oral ELEP with 500 and 750 mg/kg 
b.w.). Treatments were administered for 14 days after infection with C. 
albicans. Colony fungal loads and IgM antibodies were measured by 
counting colony forming units and flow cytometry using anti-C. albicans 
antibody kits, respectively. 
Results: Ingestion of the ELEP significantly affected fungal load clearance 
and decreased IgM antibody levels compared to that in the VCC group 
(p<0.001). Furthermore, ingestion of the ELEP was associated with 
significantly lower concentrations of IgM antibodies and colony forming 
units (p<0.001). 
Conclusions: These data strongly suggest that IgM antibody response is 
involved in of the mechanism by which ELEP decreases C. albicans 
infection. Furthermore, these results provide important information for 
the potential application of ELEP in the treatment of Balb/C mice with 
systemic candidiasis.  
Contexto: Candida albicans es un hongo patógeno que causa candidiasis 
vulvovaginal (VVC), que presenta problemas clínicos significativos en 
pacientes inmunocomprometidos. No existen estudios que correlacionen 
las respuestas de anticuerpos IgM y cargas fúngicas después del uso del 
extracto etanólico de hoja de Plectranthus scutellarioides (L.) R.Br. (ELEP) 
en VVC.  
Objetivos: Examinar la carga fúngica de colonias, la respuesta de 
anticuerpos IgM y su correlación en ratones Balb/c infectados con C. 
albicans tratados con ELEP administrado por vía oral. 
Métodos: Veinticinco ratones Balb/c hembras se dividieron en cinco 
grupos (cinco ratones/grupo): grupo normal (ELEP oral no infectado), 
grupo control VVC (infectado + 0,2 mL salino oral), tratado con 
ketoconazol en el grupo VCC (VVC + agentes antifúngicos orales) y dos 
grupos de tratamiento (VVC + ELEP oral con 500 y 750 mg/kg p.c.). Los 
tratamientos se administraron durante 14 días después de la infección con 
C. albicans. Las cargas fúngicas y los anticuerpos IgM se midieron 
contando unidades formadoras de colonias y citometría de flujo usando 
kits de anticuerpos anti-C. albicans, respectivamente. 
Resultados: La ingestión de ELEP afectó el aclaramiento de la carga 
fúngica y la disminución de los niveles de anticuerpos IgM en 
comparación con el grupo VCC (p<0,001). Además, la ingestión de ELEP 
se asoció con concentraciones más bajas de anticuerpos IgM y unidades 
formadoras de colonias (p<0,001). 
Conclusiones: Estos datos sugieren que la respuesta de anticuerpos IgM 
está implicada en el mecanismo por el cual ELEP disminuye la infección 
por C. albicans. Además, estos resultados proporcionan información 
importante para la aplicación potencial de ELEP en el tratamiento de 
ratones Balb/c con candidiasis sistémica.  
Keywords: anti-candida; immune response; miana leaves; vulvovaginal 
candidiasis. 
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respuesta inmune. 
 
ARTICLE INFO  
Received: May 29, 2017. 
Received in revised form: September 8, 2017. 
Accepted: September 11, 2017.  
Available Online: October 3, 2017.  
Declaration of interests: The authors declare no conflict of interest. 
Funding: This study was supported by the Ministry of Research Technology and Higher Education of the Republic of Indonesia (BPPDN 
2014-2017). 
Karo et al. IgM antibody and fungal load impacts of P. scutellarioides 
 
http://jppres.com/jppres  J Pharm Pharmacogn Res (2018) 6(1): 28 
 
 
INTRODUCTION 
Candida albicans, a polymorphic fungus, is a 
member of the normal human microbiome (Mayer et 
al., 2013). They are, however, the most common cause 
of fungal disease in humans (Karkowska-Kuleta et al., 
2009), often causing supercritical infection, because 
C. albicans can colonize the mucosal surfaces of 
healthy people and thus occurs commensally in the 
gastrointestinal tract, oral cavity, and vagina (Mavor 
et al., 2005). Moreover, C. albicans can cause life-
threatening systemic infections, making it the most 
prevalent fungal pathogen of humans (Correia et al., 
2016). Life-threatening C. albicans infections are a 
significant clinical problem, especially in immuno-
compromised individuals (Shahin et al., 2016). There 
are two mechanisms by which C. albicans can enter 
the bloodstream in humans: direct penetration 
from the epithelium after tissue damage (Mavor et al., 
2005) and dissemination from biofilms formed on 
medical devices introduced into the patient (such 
as catheters, dental implants, and intravenous 
lines) (Chandra et al., 2001).  Vulvovaginal candidiasis 
(VVC) is one of the common forms of mucosal can-
didiasis (Correia et al., 2016), and it estimated that ap-
proximately 70-75% of women suffer at least one 
episode of VVC in their lifetime (Sobel, 2007). Ap-
proximately 40-50% of these women also experi-
ence a recurrence (Sobel, 2007). A single strain causes 
frequent recurrences through subsequent infections 
(Sampaio et al., 2003). Risk factors for VVC include 
human immunodeficiency virus (HIV) infection 
(Duerr et al., 2003), diabetes, antibacterial vaginal, and 
immunogenetic alterations (Jaeger et al., 2013).  
Azole antibiotics are typically the treatment of 
choice for VVC but are limited by the development 
of azoles antibiotic resistance (Odds, 1993; Sanglard and 
Odds, 2002). Therefore, many scientific researchers 
seek plant-derived extracts and related metabolites 
due to their efficacy effects, especially for anti-
Candida (Costa et al., 2016; Salari et al., 2016; Sadowska et al., 
2017). Plant-derived drugs and related metabolites 
have been reported to be safe and without side-
effects (Obici et al., 2008; Toyang et al., 2012; Mafioleti et al., 
2013). In Indonesian traditional medicine, especially 
in Toraja communities, Plectranthus scutellarioides 
(L.) R.Br. (referred to as ‘miana’ in Indonesia) leaves 
are used to treat vaginal discharge and may there-
fore have anti-candidiasis properties. P. scutellari-
oides has antibacterial and antifungal properties 
(Grosvenor et al., 1995). To date, there are no studies on 
the use of P. scutellarioides as an anti-candidiasis 
treatment that correlated immune responses with 
decreased of colony fungal counts. This study per-
formed to estimate the colony fungi loads, IgM an-
tibody responses, and their correlation in Balb/c 
mice infected with C. albicans and treated with 
orally administered ethanol leaf extrac of Plectran-
thus scutellarioides (L.) R.Br. (ELEP). 
MATERIAL AND METHODS 
Yeast strain and reagents 
C. albicans standard strain (ATCC 10231) was 
used throughout this study from Abcam (Abcam 
Biochemicals, USA) and prepared according to fac-
tory instruction. The final preparation was sus-
pended in sterile Dulbecco’s phosphate-buffered 
saline (DPBS) (Sigma Chemical Co., St. Louis, Mo, 
USA) before use. All solvents and reagents were 
used analytical grade. 
Plant material and extraction 
The leaf of P. scutellarioides was collected from 
Indonesian Spices and Medicinal Crops Research 
Institute, West Java, Indonesia in January 2016 
(6°34’37.95” S; 106°47’20.37” E; 224.64 m a.s.l.). The 
leaf of P. scutellarioides was identified by Dr. Joem 
Setijo Rahajoe at the Herbarium Bogoriense of the 
Indonesia Institute of Sciences (LIPI), Bogor, West 
Java, Indonesia. A voucher specimen was deposited 
at the Herbarium Bogoriense (number 2395). The 
extraction method was conducted based on solvent 
maceration (Nurcholis et al., 2016) with slight modifica-
tion. Briefly, the air-dried powdered leaves of P. 
scutellarioides (one kg) were extracted with 96% 
ethanol (1:5 w/v) at room temperature for 24 h. The 
mixture was filtered through Whatman 4 paper and 
evaporated to dryness under vacuum with an evap-
orator (BUCHI, R-250, Switzerland). These extracts 
were then used for analysis. 
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Animals 
Twenty-five 8-to-12 week female Balb/c mice 
were obtained from Laboratory Molecular Biology 
and Immunology, Faculty of Medicine, Hasanuddin 
University, Makassar City, South Sulawesi, Indone-
sia. The mice were housed in standard environmen-
tal conditions and fed with rodent standard diets 
and water ad libitum at the animal research unit of 
Hasanuddin University. All procedures used in 
these studies were approved by the Animal Care 
and Use Committee at Faculty Medicine, Ha-
sanudin University (UH16010010 on March 7, 2016). 
Mice were anesthetized by inhalation with ether 
and dislocated by stretching of the spinal cord. A 
minimum number of animals were used to obtain 
reliable results, and all animals were handled in ac-
cordance with the NIH Guide for the Care and Use 
of Laboratory Animals, NIH Publication No. 85-23, 
1985, revised 1996.  
Intravaginal infection with Candida albicans, 
colony fungal load and IgM antibody responses 
Mice were infected intravaginally with C. albi-
cans suspended in DPBS (1 x 10-2 yeast cell/mouse), 
except for the normal group. Twenty-five female 
Balb/c mice were divided into five groups: the VVC 
control (VCC, n = 5) received 0.2 mL saline orally; 
the ketoconazole-treated VCC group (VCK) re-
ceived ketoconazole (200 mg/kg b.w. given orally); 
the ELEP500 and ELEP750 groups were orally given 
doses of 500 mg/kg b.w. and 750 mg/kg b.w., re-
spectively. The doses were selected based on previ-
ously published studies and traditional use (Pakadang 
et al., 2015). The treatment was done in 1 to 14 days 
after infection the mice given orally. After anesthe-
sia by inhalation with ether, the spinal cords of the 
mice were dislocated by stretching. Colony fungi 
loads and IgM antibody responses were monitored 
for 14 days. The colony fungal load was examined by 
taking a vaginal swab, culturing, and counting the 
number of resulting C. albicans colonies (Conti et al., 
2014); results are shown as colony forming units 
(CFU) in the vaginal fluid (mL). Serum was collect-
ed from the submaxillary vein in mice and used for 
IgM analysis. The concentrations of IgM antibody 
were measured using ELISA kits for anti-Candida 
albicans (ab53891, Abcam, USA) according to 
manufacturer’s protocol. The serum samples were 
measured using a microplate reader (Biotek, USA) 
at 450 nm, and IgM antibody expressed in pg/mL 
according to a standard curve. 
Chemical characterization 
The presence of different secondary metabolites 
like alkaloids, flavonoids, saponins, phenols, tan-
nins, glycosides, triterpenes, and steroids in the 
ethanolic extract of P. scutellarioides were analyzed 
by using standard phytochemical procedures de-
scribed by Waras et al. (2015). The color intensity or 
the precipitate formation was used as analytical re-
sponses to these tests. Briefly, Meyer’s, Wagner’s 
and Dragendroff reagents were used for alkaloid. 
Mg2+ and HCl in ethanol were used for flavonoid. 
Foam test was used for saponins. FeCl3 1% was used 
for phenol and tannins test. Keller-Killani test was 
used for glycosides.  Lieberman-Burchard reagents 
was used for triterpenes and steroids test. 
Statistical analysis 
Data is shown as mean ± SEM. Comparison be-
tween groups was analyzed by one-way ANOVA 
with the Tukey's multiple comparisons test; a p-
value <0.05 was considered statistically significant. 
Pearson correlation with simple model regression 
was used to assess the association between level of 
colony fungal load and IgM antibody responses. 
 
RESULTS 
The first secondary metabolites screening con-
firmed the presence of alkaloid, glycoside, saponins, 
triterpenes, flavonoids, and phenols in the crude 
ethanolic extract of P. scutellarioides (Table 1). Sec-
ondary metabolites of steroids and tannins were 
absent from the crude ethanolic extract of P. scutel-
larioides (Table 1). 
An anti-candidiasis study was done on mice in-
fected with C. albicans; the mice were orally admin-
istered a crude ethanolic extract of P. scutellari-
oides. IgM antibody levels and colony fungal loads 
were monitored for 14 days; the results are shown in 
Figure 1. The highest IgM antibody response was 
1.191 pg/mL from the VVC control (VCC) group, fol-
lowed by P. scutellarioides extract of 500 mg/kg b.w 
(CSE500, 1.001 pg/mL), ketoconazole-treated VVC 
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group (VCK, 0.519 pg/mL), P. scutellarioides extract 
of 750 mg/kg b.w (CSE750, 0.518 pg/mL), and nor-
mal (0.217 pg/mL) groups (Fig. 1A). P. scutellarioides 
extract at the doses tested (500 mg/kg and 750 
mg/kg b.w) decreased IgM levels compared with 
VCC. In both the ELEP750 and VCK groups, the de-
crease in IgM levels was significant (p<0.001) com-
pared to IgM levels in the VCC group at 14 days. 
Furthermore, IgM levels in the ELEP750 and VCK 
groups were not significantly different from the 
normal group 14 days. The results obtained from 
the present study of the effect of the ethanolic ex-
tract on decreasing colony fungal loads are present-
ed in Fig. 1B. The mice infected with C. albicans 
(VCC group) had significantly more colony fungal 
units per mL vaginal fluid (46.52 CFU/mL) 
(p<0.001) compared to the VCK and ELEP750 
groups, with values of 18.00 CFU/mL and 18.92 
CFU/mL, respectively.  
Table 1. Secondary metabolites screening of the ethanolic ex-
tract of P. scutellarioides. 
Name of secondary metabolites Observation 
Alkaloid + 
Glycoside + 
Saponins + 
Triterpenes + 
Steroids - 
Flavonoids + 
Phenols + 
Tannins - 
 (+) = presence of metabolites; (-) = absence of metabolites 
A positive correlation was seen between the IgM 
antibody response and colony fungal loads after C. 
albicans infection and treatment with a crude etha-
nolic extract of P. scutellarioides (Fig. 2). As shown 
in Fig. 2 A-D, the Pearson correlation coefficient 
and p values between IgM antibody response and 
colony fungal load were 0.9745 and <0.0001 in the 
VCC group, 0.9307 and <0.0001 in the VVK group, 
0.9598 and <0.0001 in the ELEP500 group, and 
0.9168 and <0.0001 in the ELEP750 group. These 
findings demonstrated significant decrease in colo-
ny forming units and IgM antibody levels in the 
ELEP750, ELEP500 and VVK groups when com-
pared with the VCC group. 
A 
 
B 
 
Figure 1. Potency of ethanol leaf extract of P. scutellarioides 
(ELEP) on IgM antibody response (A) and decreased colony 
fungal loads (CFU) level (B).  
Mice were infected with C. albicans (1 x 10-2 CFU/mouse) intra-
vaginally, except in the normal group (received 500 mg/kg ELEP 
b.w. and saline). Vulvovaginal candidiasis control (VCC) received 
saline; ketoconazole-treated in the vulvovaginal candidiasis group 
(VCK) received ketoconazole (200 mg/kg b.w.); the ELEP groups 
were orally given doses of 500 mg/kg b.w. (ELEP500) and 750 
mg/kg b.w. (ELEP750). Values presented are the mean ± SEM, n = 5. 
This experiment terminated at day 14. *** and ****, differed 
significantly from VCC at p<0.001 and P < 0.0001, respectively; # and 
##, differed from VCK at p<0.05 and p<0.01, respectively; $ and $$$, 
differed from normal at p<0.05 and p<0.001, respectively. 
DISCUSSION  
C. albicans is a major fungal pathogen of hu-
mans, and mortality among infected patients is 
high (Karkowska-Kuleta et al., 2009). VVC is an acute in-
flammatory disease caused by C. albicans infection 
that causes clinical signs and symptoms such as in-
tense pruritus, vaginal discharge, an erythematous 
vulva and dyspareunia (Cassone, 2015). VVC can be 
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caused by multifactorial issues, such as genetic pre-
disposition, pregnancy, contraceptives, diabetes 
mellitus, antibiotics; behavioral factors such as fe-
male hygiene habits; and other factors such as iron 
deficiency (Sobel, 2007). The azole antibiotics are the 
treatment of choice for VVC (Sobel, 2007; Chew and 
Than, 2016), but its use has various problems, includ-
ing resistance, toxicity and side effects (Bodey, 1992; 
Cleary et al., 2013). Currently, many researchers are 
focusing on bioactive medicinal plants to find anti-
fungal alternative for the treatment of candidiasis. 
Zhang et al. (2013) showed 15 extracts from 58 plant 
extracts possess anti-fungal activity for C. albicans. 
Also, five Indian medicinal plants viz. Clerodendron 
colebrookianum Walp. (leaf), Gnetum gnemon L. 
(leaf), Sarcochlamys pulcherrima (Roxb.) Gaud. 
(leaf), Garcinia lancifolia (Don) Roxb (leaf) and Eu-
ryale ferox Salisb. (seed) showed anticandidal activi-
ty (Mazumder et al., 2012). This finding is important for 
the development of an effective VVC therapy. 
In Indonesia, especially Minahasa communities, 
P. scutellarioides is traditionally used to treat vagi-
nal discharge. This study was performed to evaluate 
the anticandidal activity of a crude ethanolic extract 
of P. scutellarioides in mice infected with C. albi-
cans. Results showed that C. albicans yeast cells 
treated with P. scutellarioides extract (750 mg/kg 
b.w.) had 18.92 CFU/mL (Fig. 1), whereas untreated 
(VCC) yeast cells had 46.52 CFU/mL, resulting in a 
CFU reduction up to approximately 59%. 
 
 
 
Figure 2. Scatter plot depicting the correlation between IgM antibody profile and colony fungal loads at vulvovaginal candidiasis 
control (A); ketoconazole-treated in vulvovaginal candidiasis group (B); and treatment groups of P. scutellarioides extract doses of 
500 mg/kg b.w. (C) and 750 mg/kg b.w. (D).  
The x-axis represents the C. albicans fungal load, while Y-axis represents the level of IgM antibody in pg/mL. Pearson’s correlation 
coefficient (r) and p value are given in the separate graph. Each point corresponds to one group. The solid line exhibits the best 
line fitted to the data based on the simple regression model. 
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In addition, when treated with 500 mg/kg b.w 
(ELEP500) P. scutellarioides extract and ketocona-
zole (VVK), there was more than 16% and 61% CFU 
reduction, respectively. The data presented here 
indicate that ingestion of a ELEP was associated 
with significantly lower IgM antibody response at 14 
days after infection of C. albicans (Fig. 1) compared 
with the VCC group. Consistent with their lower 
IgM antibody levels in serum, ELEP-treated mice 
also had lower fungal loads of yeast (CFU) at 14 
days after infection. These findings are consistent 
with the traditional use of P. scutellarioides leaf. 
These results indicate that innate immunity is im-
portant as the first line to protect of the host 
against systemic candidiasis. It confirms results by 
Soltani et al. (2012) that macrophages have an im-
portant role in recognizing and eliminating invasive 
candidiasis. Previous studies have shown that vari-
ous pharmacology activities for P. scutellarioides are 
associated with anticandidal activity. Pakadang et 
al. (2015) showed influence on the immune defense 
by oral administration of P. scutellarioides ethanolic 
extract in rats with resistance against tuberculosis 
infection. In addition, some researchers have also 
shown that potency of P. scutellarioides leaves as 
antimicrobial agents, such as the ethyl acetate frac-
tion against Staphylococcus aureus, C. albicans and 
Salmonella thyposa (Effendi, 2010) and balm extract 
against scar infected S. aureus on the rabbit 
(Marpaung, 2014). 
This study shows that the anticandidal activity of 
P. scutellarioides extracts (750 mg/kg b.w.) was the 
same potency with ketoconazole (200 mg/kg b.w.) 
for an enhanced killing of the C. albicans cells. 
Thus, ELEP and ketoconazole may exercise anti-
candidal activity via similar mechanisms of action 
through the inhibition of the fungal cytochrome 
P450, which is essential for the biosynthesis of er-
gosterol as a component of fungal plasma mem-
brane (White et al., 1998). The ELEP contained flavo-
noid metabolite (Table 1); it may be another mech-
anism of anticandidal activity in ELEP. Some anti-
candidal properties of flavonoids as have been re-
ported, such as inhibition of colony growth (Yoon et 
al., 2006; Herrera et al., 2010), inhibition of efflux pump 
and induction of apoptosis (Serpa et al., 2012; Zuzarte et 
al., 2012), cell wall damage (Sitheeque et al., 2009), and 
cytoplasmic membrane disruption (Zuzarte et al., 2012). 
This result indicates the need to further identify 
bioactive compounds responsible for the antican-
didal activity, especially in the treatment of VVC. 
CONCLUSIONS 
Positive correlations between fungal loads clear-
ance and decreased IgM antibody levels have been 
found in mice infected with C. albicans and orally 
treated with ELEP. Thus, it suggested that the IgM 
immune response is involved in the mechanism by 
which ELEP decreases C. albicans infection. In an 
ethanolic extract of P. scutellarioides, there are po-
tential sources of bioactive compounds; further 
study should be performed to identify the bioactive 
compounds responsible for the anticandidal activi-
ty. 
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